StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Other Business Activities by Year

Other Business Activities (PC1, R&D platforms & corporate research) — Pretax loss ($M) ($M)

Pfizer Other Business Activities: -$8,199M in FY2025, up 13.7% from a year earlier.

Latest, FY2025
-8,199
Period ended Dec 31, 2025
Change on a year earlier
+13.7%
-7,213 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-Q / 10-K Note 17 — Segment Reporting (ASU 2023-07 Significant Segment Expenses).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Business Activities (PC1, R&D platforms & corporate research) — Pretax loss ($M) ($M)Year on yearSource
FY2025Dec 31, 2025-8,199+13.7%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 2024-7,213+72.4%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 2023-4,185-18.9%Form 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 2022-5,162-61.6%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 2021-13,455+6.9%Form 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 2020-12,583+12.2%Form 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 2019-11,216+75.7%Form 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 2018-6,383+1.3%Form 10-K (filed 2020-02-27) ↗
FY2017Dec 31, 2017-6,299+15.6%Form 10-K (filed 2020-02-27) ↗
FY2016Dec 31, 2016-5,448-2.8%Form 10-K (filed 2019-02-28) ↗
FY2015Dec 31, 2015-5,607–Form 10-K (filed 2018-02-22) ↗

Cite this data

StockData. (2026). Pfizer Other Business Activities ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/seg-ebt-oba

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.